Geoffrey S. Gottlieb

Immunology and MicrobiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 22 papers. Top paper: “An HIV Epidemic Model Based on Viral Load Dynamics: Value in Assessing Empirical Trends in HIV Virulence and Community Viral Load”.

An HIV Epidemic Model Based on Viral Load Dynamics: Value in Assessing Empirical Trends in HIV Virulence and Community Viral Load

PLoS Computational Biology(2014)10.1371/journal.pcbi.1003673

N/A

1.6DataRank · unranked

29 citations

John E. Mittler, Geoffrey S. Gottlieb, James I. Mullins, Joshua T. Herbeck

Resource and infrastructure challenges on the RESIST-2 Trial: an implementation study of drug resistance genotype-based algorithmic ART switches in HIV-2-infected adults in Senegal

Trials(2021)10.1186/s13063-021-05902-5

N/A

0.208DataRank · unranked

3 citations

Khardiata Diallo, Mouhamadou Baïla Diallo, Dominique Faye, Ousseynou Cisse, Robert A. Smith +11 more

Expanded Spectrum of Antiretroviral-Selected Mutations in Human Immunodeficiency Virus Type 2

The Journal of Infectious Diseases(2020)10.1093/infdis/jiaa026

N/A

0DataRank · unranked

26 citations

Diane Descamps, Soo‐Yon Rhee, Dana N. Raugi, Charlotte Charpentier, Nuno Taveira +7 more

Risk compensation after HIV-1 vaccination may accelerate viral adaptation and reduce cost-effectiveness: a modeling study

medRxiv(2020)10.1101/2020.12.13.20248146

N/A

0DataRank · unranked

0 citations

John E. Mittler, Steven M. Goodreau, James T. Murphy, Molly C. Reid, Neil F. Abernethy +4 more

The impact of food insecurity on HIV outcomes in Senegal, West Africa: a prospective longitudinal study

BMC Public Health(2021)10.1186/s12889-021-10444-1

N/A

0DataRank · unranked

26 citations

Jacques F. Sambou, Sanou Ndong, Mouhamadou Baïla Diallo, Ibrahima Tito Tamba, Dominique Faye +13 more

Impact of Traditional Healers on the HIV Care Cascade in Senegal, West Africa: A Longitudinal Study

American Journal of Tropical Medicine and Hygiene(2021)10.4269/ajtmh.21-0280

N/A

0DataRank · unranked

6 citations

Jacques F. Sambou, Sanou Ndong, Mouhamadou Baïla Diallo, Ibrahima Tito Tamba, Dominique Faye +12 more

Food insecurity predicts loss to follow-up among people living with HIV in Senegal, West Africa

AIDS Care(2021)10.1080/09540121.2021.1894316

N/A

0DataRank · unranked

9 citations

Jacques F. Sambou, Sanou Ndong, Mouhamadou Baïla Diallo, Ibrahima Tito Tamba, Dominique Faye +12 more

Risk compensation after HIV-1 vaccination may accelerate viral adaptation and reduce cost-effectiveness: a modeling study

Scientific Reports(2021)10.1038/s41598-021-85487-w

N/A

0DataRank · unranked

8 citations

John E. Mittler, Steven M. Goodreau, James T. Murphy, Molly C. Reid, Neil F. Abernethy +4 more

Test-and-treat coverage and HIV virulence evolution among men who have sex with men

Virus Evolution(2021)10.1093/ve/veab011

N/A

0DataRank · unranked

3 citations

Joshua T. Herbeck, Geoffrey S. Gottlieb, Neil F. Abernethy, James T. Murphy, John E. Mittler +2 more

SARS-CoV-2 Epidemiology on a Public University Campus in Washington State

medRxiv(2021)10.1101/2021.03.15.21253227

N/A

0DataRank · unranked

6 citations

Sarah L Sohlberg, Jessica O’Hanlon, Amanda M. Casto, Anne Emanuels, Natalie Lo +31 more

HIV-2 Drug Resistance Genotyping from Dried Blood Spots

Journal of Clinical Microbiology(2020)10.1128/jcm.02303-20

N/A

0DataRank · unranked

6 citations

Robert S. Nixon, Sally Leong, Khadim Faye, Jean Phillipe Diatta, Fatima Sall +6 more

Effect of Human Immunodeficiency Virus Infection on Human Papillomavirus Clearance Among Women in Senegal, West Africa

The Journal of Infectious Diseases(2022)10.1093/infdis/jiac428

N/A

0DataRank · unranked

5 citations

Rachel L. Winer, Selly Ba, Marie Pierre Sy, John Lin, Qinghua Feng +5 more

Why does age at HIV infection correlate with set point viral load? An evolutionary hypothesis

Epidemics(2022)10.1016/j.epidem.2022.100629

N/A

0DataRank · unranked

1 citations

Sarah E. Stansfield, John E. Mittler, James T. Murphy, Neil F. Abernethy, Geoffrey S. Gottlieb +5 more

Duration of viral infectiousness and correlation with symptoms and diagnostic testing in non-hospitalized adults during acute SARS-CoV-2 infection: A longitudinal cohort study

Journal of Clinical Virology(2023)10.1016/j.jcv.2023.105420

N/A

0DataRank · unranked

22 citations

Ronit R. Dalmat, Linhui Hao, Meagan J. Bemer, Elvira Budiawan, Jennifer F. Morton +21 more

Antiviral Activity of Lenacapavir Against Human Immunodeficiency Virus Type 2 (HIV-2) Isolates and Drug-Resistant HIV-2 Mutants

The Journal of Infectious Diseases(2023)10.1093/infdis/jiad562

N/A

0DataRank · unranked

16 citations

Dana N. Raugi, Robert S. Nixon, Moussa Seydi, Nicolas Margot, Christian Callebaut +43 more

Intrinsic resistance of HIV-2 and SIV to the maturation inhibitor GSK2838232

PLoS ONE(2023)10.1371/journal.pone.0280568

N/A

0DataRank · unranked

3 citations

Dana N. Raugi, Robert S. Nixon, Jennifer Song, Moussa Seydi, Geoffrey S. Gottlieb +1 more

Dolutegravir-based Antiretroviral Therapy for Human Immunodeficiency Virus Type 2 (HIV-2) Infection: Progress for People With HIV-2

Clinical Infectious Diseases(2023)10.1093/cid/ciad340

N/A

0DataRank · unranked

0 citations

Geoffrey S. Gottlieb

Type 1 Human Immunodeficiency Virus (HIV-1) Incidence, Adherence, and Drug Resistance in Individuals Taking Daily Emtricitabine/Tenofovir Disoproxil Fumarate for HIV-1 Pre-exposure Prophylaxis: Pooled Analysis From 72 Global Studies

Clinical Infectious Diseases(2024)10.1093/cid/ciae143

N/A

0DataRank · unranked

19 citations

Tao Li, Juan Yang, Melanie de Boer, Christoph C Carter, Moupali Das +58 more

HIV Resistance to Dolutegravir Varies With Coadministered Agents

Clinical Infectious Diseases(2025)10.1093/cid/ciaf481

N/A

0DataRank · unranked

2 citations

Ceejay L. Boyce, M. Bishop, Alyssa Oldroyd, Louise D. V. du Toit, Amashnee Saimen +22 more

Enhancing SARS-CoV-2 response capacity in Africa and other centers for research in emerging infectious diseases centres through a collaborative training programme

Clinical Microbiology and Infection(2025)10.1016/j.cmi.2025.10.002

N/A

0DataRank · unranked

0 citations

Abdou Padane, Alioune Gaye, Anavaj Sakuntabha, Awa B. Dème, Badara Cissé +23 more

Spectrum of Activity of Raltegravir and Dolutegravir Against Novel Treatment-Associated Mutations in HIV-2 Integrase: A Phenotypic Analysis Using an Expanded Panel of Site-Directed Mutants

The Journal of Infectious Diseases(2022)10.1093/infdis/jiac037

N/A

0DataRank · unranked

8 citations

Vincent H. Wu, Jennifer Song, Dana N. Raugi, Khardiata Diallo Mbaye, Moussa Seydi +2 more

Long-term Experience and Outcomes of Programmatic Antiretroviral Therapy for Human Immunodeficiency Virus Type 2 Infection in Senegal, West Africa

Clinical Infectious Diseases(2020)10.1093/cid/ciaa277

N/A

0DataRank · unranked

15 citations

Selly Ba, Ousseynou Cisse, Khardiata Diallo, Ibrahima Tito Tamba, Cheikh Tidiane Ndour +64 more